🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

TRIS: Contingency Management App for Alcohol Use Disorder

RecruitingNAAges 18 Years - 70 YearsAllUniversity of Sao Paulo General Hospital
NCT07735585 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Alcohol Use Disorder (AUD) is a major public health concern associated with substantial morbidity, mortality, and impaired social and occupational functioning. Contingency Management (CM) is an evidence-based behavioral intervention that provides incentives contingent on abstinence and has demonstrated effectiveness in the treatment of substance use disorders. This study will evaluate the efficacy of Tratamento Remoto com Incentivos à Sobriedade (TRIS), a Brazilian mobile health application that integrates a smartphone app with a Bluetooth-enabled breathalyzer (BACtrack) to deliver remote CM for AUD. Participants will be randomized to receive either standard outpatient treatment plus TRIS-based CM or standard outpatient treatment with remote alcohol monitoring only. The primary objective is to determine whether TRIS-based CM increases biochemically verified alcohol abstinence compared wi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Able to read and speak Portuguese. * Provide signed informed consent. * Age 18 to 70 years. * Alcohol consumption within the past month. * Current diagnosis of Alcohol Use Disorder (AUD). * Seeking treatment for AUD at AME Vila Maria or Instituto Perdizes. * Breath alcohol concentration (BrAC) of 0.00 at the time of consent. * Own and be able to operate a smartphone with an active mobile service plan. * Smartphone compatible with the Bluetooth frequency required for the BACtrack breathalyzer. Exclusion Criteria: * Crack cocaine use within the past 90 days. * Any seizure episode within the past 12 months. * Diagnosis of a psychotic disorder (DSM-5). * Suicide attempt within the past two years. * Any medical or psychiatric condition that may compromise safe participation, as determined by the study medical director.
💊

What it tests

  • Remote Contingency Management (CM)
  • Treatment as Usual (TAU)
📍

Where

1 site
IPER Research Center
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy